_1777370220974_847775619.png&w=48&q=75){kind=small}
_1777370193195_831968492.png&w=48&q=75){kind=small}
Potential new treatment advances cancer care
A late-stage trial of a personalized cancer treatment based on mRNA technology has successfully met its goals in treating melanoma, potentially representing a significant advancement in cancer care. Developed by Moderna and Merck, this innovative therapy leverages mRNA to target cancer cells, marking a major step forward in cancer treatment efforts.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)